Literature DB >> 2024456

Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy.

K Shirasuna1, Y Hayashido, M Sugiyama, H Yoshioka, T Matsuya.   

Abstract

The immunohistochemical localizations of human epidermal growth factor (hEGF) and EGF receptor (EGFr) in oral tissues, including normal mucosa, leukoplakia and squamous cell carcinoma were examined by the use of monoclonal antibodies to hEGF and EGFr. In normal mucosa and leukoplakia, immunostaining of hEGF was limited to an underlying layer of connective tissue near the epithelium. The intensity of extracellular staining appeared to increase with the degree of epithelial malignancy and was eventually most striking in the stroma of invasive carcinoma. The epithelial cells in normal mucosa, leukoplakia, and squamous cell carcinoma showed negligible immunoreactivity for hEGF. Expression of EGFr appeared to be associated with the proliferative activity of cells and/or epithelial malignancy. In normal mucosa, anti-EGFr monoclonal antibody reacted only with the basal cell layer. In all sections of leukoplakia, the positive cells for EGFr were found in the prickle cell layer in addition to the basal cell layer. Most tumour cells in squamous cell carcinoma were strongly positive for EGFr. These findings indicate increased expression of hEGF and EGFr with malignancy. The characteristic localization of extracellular hEGF in the underlying connective tissue and in stroma of oral mucosal tumours suggests a possible epithelial-mesenchymal interaction in hEGF secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024456     DOI: 10.1007/bf01600165

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  21 in total

1.  Isolation and structure of urogastrone and its relationship to epidermal growth factor.

Authors:  H Gregory
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

2.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

3.  Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.

Authors:  M Mori; R Naito; K Tsukitani; Y Okada; T Hayashi; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.

Authors:  Y Hirata; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1979-04       Impact factor: 5.958

5.  Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

Authors:  P U Heitz; M Kasper; S van Noorden; J M Polak; H Gregory; A G Pearse
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

6.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

7.  Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue.

Authors:  J H Mydlo; J Michaeli; C Cordon-Cardo; A S Goldenberg; W D Heston; W R Fair
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

8.  Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture.

Authors:  M Kurobe; S Furukawa; K Hayashi
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

9.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

10.  Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases.

Authors:  J Bánóczy; A Csiba
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1976-12
View more
  7 in total

1.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo.

Authors:  N S Soukos; M R Hamblin; S Keel; R L Fabian; T F Deutsch; T Hasan
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

2.  Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.

Authors:  Kaisa Erjala; Misa Raitanen; Jarmo Kulmala; Reidar Grénman
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-05       Impact factor: 4.553

3.  Epidermal growth factor in the oesophagus.

Authors:  J Jankowski; G Coghill; B Tregaskis; D Hopwood; K G Wormsley
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

Review 4.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

5.  Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.

Authors:  S S Prime; S M Game; J B Matthews; A Stone; M J Donnelly; W A Yeudall; V Patel; R Sposto; A Silverthorne; C Scully
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

6.  Expression of epithelial growth factor receptor in oral epithelial dysplastic lesions.

Authors:  Manickam Rajakili Chockalingam Rajeswari; Thillai Rajasekaran Saraswathi
Journal:  J Oral Maxillofac Pathol       Date:  2012-05

7.  Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.

Authors:  Hiroshi Kobayashi; Kenichi Kumagai; Akito Gotoh; Takanori Eguchi; Hiroyuki Yamada; Yoshiki Hamada; Satsuki Suzuki; Ryuji Suzuki
Journal:  Int J Oral Sci       Date:  2013-03-15       Impact factor: 6.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.